Myopathies Clinical Trials

3 recruiting

Frequently Asked Questions

Common questions about Myopathies clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 82 trials

Recruiting
Phase 1Phase 2

A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)

Idiopathic Inflammatory MyopathiesSystemic Sclerosis
Nkarta, Inc.144 enrolled15 locationsNCT06733935
Recruiting

Muscle Health Measurements Using Electrical Impedance Myography

Muscular DystrophiesMyositisCongenital Myopathy+4 more
Beth Israel Deaconess Medical Center150 enrolled1 locationNCT07502989
Recruiting

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

CardiomyopathiesSudden Cardiac DeathCardiac Arrest+1 more
Idoven 1903 S.L.5,342 enrolled14 locationsNCT05890716
Recruiting
Phase 1

Phase IA and IB Study of AAVrh.10hFXN Gene Therapy for the Cardiomyopathy of Friedreich's Ataxia

CardiomyopathiesFriedreich AtaxiaMyocardial Fibrosis+1 more
Weill Medical College of Cornell University25 enrolled1 locationNCT05302271
Recruiting
Phase 3

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

CardiomyopathiesAmyloidosisHeart Diseases+3 more
Eidos Therapeutics, a BridgeBio company582 enrolled98 locationsNCT06563895
Recruiting

The Heart Hive - Cardiomyopathy Study

CardiomyopathiesMyocarditis
Imperial College London10,000 enrolled1 locationNCT04612296
Recruiting
Phase 4

The PIVATAL Study -Study of Ventricular Arrhythmia (VTA) Ablation in Left Ventricular Assist Device (LVAD) Patients

CardiomyopathiesArrythmia
University of Rochester100 enrolled19 locationsNCT05034432
Recruiting

Natural History Study for Patients With Nemaline Myopathy in Spain

Cohort StudiesNemaline MyopathyMyopathies+13 more
Hospital Universitari Vall d'Hebron Research Institute100 enrolled1 locationNCT07488806
Recruiting
Phase 1

A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.

Rheumatoid ArthritisSystemic Lupus ErythematosusIdiopathic Inflammatory Myopathies
AstraZeneca72 enrolled33 locationsNCT06916806
Recruiting

Genetic and Physical Study of Childhood Nerve and Muscle Disorders

Muscular DystrophiesMuscle MyopathiesHereditary Spastic Paraplegias+2 more
National Institute of Neurological Disorders and Stroke (NINDS)9,300 enrolled1 locationNCT01568658
Recruiting

PPG to Predict Ejection Fraction and Other Echographic Data in the General Population

CardiomyopathiesValvular Heart DiseasePericardial Disease
Tulane University500 enrolled3 locationsNCT04843371
Recruiting

PKP2-ACM Natural History Study

CardiomyopathiesCardiovascular DiseasesHeart Diseases
Rocket Pharmaceuticals Inc.36 enrolled3 locationsNCT06644742
Recruiting
Not Applicable

Inspiratory Muscle Training in Patients With Inflammatory Myopathy

Inflammatory Myopathies
Józef Piłsudski University of Physical Education33 enrolled1 locationNCT07274267
Recruiting

Mitochondrial Substrate Utilization in the Diabetic Human Heart

Heart FailureInsulin ResistanceMitochondrial Diseases+2 more
Heinrich-Heine University, Duesseldorf500 enrolled1 locationNCT05958706
Recruiting
Not Applicable

Radiotherapy vs Catheter Ablation for Ventricular Tachycardia in Structural Heart Disease

CardiomyopathiesArrhythmias, CardiacVentricular Tachycardia+1 more
Western Sydney Local Health District60 enrolled1 locationNCT06360939
Recruiting
Phase 1

Validation of Nanosensor Oxygen Measurement

MItochondrial Myopathies
Children's Hospital of Philadelphia96 enrolled1 locationNCT06819683
Recruiting
Phase 1

A Study of AZD0120 in Autoimmune Diseases

Rheumatoid ArthritisIdiopathic Inflammatory MyopathiesSystemic Sclerosis
AstraZeneca27 enrolled18 locationsNCT07295847
Recruiting
Phase 2

Phase 2 Study of Rapcabtagene Autoleucel in Myositis

Idiopathic Inflammatory Myopathies
Novartis Pharmaceuticals123 enrolled55 locationsNCT06665256
Recruiting
Phase 1

A Study of LUCAR-G79D in Subjects With Relapsed/Refractory Systemic Lupus Erythematosus (r/r SLE) and Idiopathic Inflammatory Myopathies (r/r IIM)

Systemic Lupus Erythematosus (SLE)Idiopathic Inflammatory Myopathies(IIM)
Nanjing Legend Biotech Co.38 enrolled5 locationsNCT07331272
Recruiting
Phase 2

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

Heart FailureCardiomyopathiesCardiogenic Shock+1 more
Stanford University50 enrolled5 locationsNCT06080074